LEADER 01839nam  2200445z- 450 
001 9910345961703321
005 20210211
035   $a(CKB)4920000000094097
035   $a(oapen)https://directory.doabooks.org/handle/20.500.12854/55902
035   $a(oapen)doab55902
035   $a(EXLCZ)994920000000094097
100   $a20202102d2018      |y         0
101 0 $aeng
135   $aurmn|---annan
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 00$aPediatric Venous Thromboembolism
210   $cFrontiers Media SA$d2018
215   $a1 online resource (116 p.)
225 1 $aFrontiers Research Topics
311 08$a2-88945-639-0 
330   $aVenous thromboembolism (VTE) occurs less often in children than adults and therefore remains underrecognized despite increasing in incidence. Due to the risk of mortality, short- and long-term morbidity, and increased healthcare costs associated with pediatric VTE, this entity merits better understanding and consideration. With this Research Topic, we aim to highlight some special considerations of pediatric VTE, namely risk factors and epidemiology, rare types of pediatric thrombosis and considerations unique to specific clinical patient subgroups, approaches to management and treatment, and prevention
606   $aMedicine$2bicssc
610   $aEpidemiology
610   $aManagement
610   $aPediatrics
610   $aprevention
610   $aRisk factors
610   $aThrombosis
610   $aTreatment
610   $aVenous Thromboembolism
615  7$aMedicine
700   $aJulie Jaffray$4auth$01279229
702   $aBrian R. Branchford$4auth
702   $aArash Mahajerin$4auth
906   $aBOOK
912   $a9910345961703321
996   $aPediatric Venous Thromboembolism$93014845
997   $aUNINA